Nicholas P. Cross

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications

Adapting UK Clinical Practise in Chronic Myeloid Leukaemia in Chronic Phase to Contemporary Management Recommendations: The ADAPT 2.0 Survey.

Adapting UK Clinical Practise in Chronic Myeloid Leukaemia in Chronic Phase to Contemporary Management Recommendations: The ADAPT 2.0 Survey.

Journal: European journal of haematology
Published: February 06, 2026

Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline.

Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline.

Journal: British journal of haematology
Published: September 15, 2025

Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes.

Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes.

Journal: Leukemia
Published: June 19, 2025

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Journal: Leukemia
Published: May 29, 2025

Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1.

Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1.

Journal: Scientific reports
Published: March 29, 2025

Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40.

Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40.

Journal: Blood
Published: January 17, 2025

Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.

Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.

Journal: Blood
Published: December 09, 2024

How I diagnose and treat myeloid/lymphoid neoplasms with tyrosine kinase gene fusions.

How I diagnose and treat myeloid/lymphoid neoplasms with tyrosine kinase gene fusions.

Journal: Blood
Published: March 19, 2024

Recommendations from the AML molecular MRD expert advisory board.

Recommendations from the AML molecular MRD expert advisory board.

Journal: Leukemia
Published: February 21, 2024

The JAK2 46/1 haplotype influences PD-L1 expression.

The JAK2 46/1 haplotype influences PD-L1 expression.

Journal: Blood
Published: February 01, 2024

Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis.

Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis.

Journal: Cancers
Published: December 11, 2023

Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.

Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.

Journal: British journal of haematology
Published: November 21, 2023
Showing 1-12 of 127

Last Updated: 09/26/2026